• Leukemia Drug for Parkinson's: A Second Look

    7 days ago - By MedPageToday

    ]]> - The chronic myeloid leukemia drug nilotinib did not produce biological or clinically meaningful effects that would benefit people with Parkinson's disease, the NILO-PD trial suggested.
    Over 6 months, nilotinib had...
    Read more ...